Beta Bionics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Beta Bionics Inc 公司

Beta Bionics, Inc. 是一家商业阶段的医疗器械公司，致力于设计、开发和商业化各种解决方案，以改善需要胰岛素的糖尿病患者 (PWD) 的健康。该公司的产品 iLet Bionic Pancreas (iLet) 是一种胰岛素输送装置，经美国食品药品管理局 (FDA) 批准，利用自适应闭环算法自主确定每次胰岛素剂量，而无需用户计算碳水化合物摄入量。iLet 用于治疗 1 型糖尿病 (T1D)。该公司的解决方案包括成人版 iLet、儿童版 iLet、Bionic Circle App 和 iLet Simulator。该公司正处于开发胰岛素泵的早期阶段，该泵旨在直接粘附在皮肤上并无需导管即可给药，在糖尿病行业中通常称为贴片泵。它还处于开发 iLet 双激素配置的早期阶段。

Beta Bionics Inc简介



公司代码BBNX

公司名称Beta Bionics Inc

上市日期Jan 30, 2025

CEOMr. Sean Saint

员工数量291

证券类型Ordinary Share

年结日Jan 30

公司地址11 Hughes

城市IRVINE

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编92618

电话19494277785

网址https://www.betabionics.com

公司代码BBNX

上市日期Jan 30, 2025

CEOMr. Sean Saint

Beta Bionics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Steven Russell, M.D., Ph.D.

Chief Medical Officer

71.02K

-1.41%

Ms. Christy Jones

Independent Director

59.44K

--

Mr. Gerard J. Michel

Independent Director

12.55K

--

Mr. Sean D. Carney

Independent Director

11.25K

--

Mr. Adam Lezack

Independent Chairman of the Board

9.84K

-12.50%

Dr. Maria Palasis, Ph.D.

Independent Director

9.84K

-12.50%

Mr. Blake Beber

Investor Relations

--

Mr. Sean Saint

President, Chief Executive Officer, Director

--

-100.00%

Mr. Dan Dearen

Independent Director

--

Mr. Stephen Feider

Chief Financial Officer

--

-100.00%

名称

名称/职务

职务

持股

持股变动

Dr. Steven Russell, M.D., Ph.D.

Chief Medical Officer

71.02K

-1.41%

Ms. Christy Jones

Independent Director

59.44K

--

Mr. Gerard J. Michel

Independent Director

12.55K

--

Mr. Sean D. Carney

Independent Director

11.25K

--

Mr. Adam Lezack

Independent Chairman of the Board

9.84K

-12.50%

Dr. Maria Palasis, Ph.D.

Independent Director

9.84K

-12.50%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2023

业务USD

名称

营收

占比

DME channel - iLet

13.41M

57.72%

DME channel - Single-use products

5.23M

22.51%

PBP channel - Single-use products

4.39M

18.89%

PBP channel - iLet

205.00K

0.88%

暂无数据

业务

地区

业务USD

名称

营收

占比

DME channel - iLet

13.41M

57.72%

DME channel - Single-use products

5.23M

22.51%

PBP channel - Single-use products

4.39M

18.89%

PBP channel - iLet

205.00K

0.88%

股东统计

更新时间: 9月3日周三

持股股东

股东类型

持股股东

占比

Eventide Asset Management, LLC

11.20%

Farallon Capital Management, L.L.C.

9.55%

Wellington Management Company, LLP

8.86%

Soleus Capital Management, L.P.

8.68%

Sands Capital Ventures LLC

8.11%

其他

53.60%

持股股东

占比

Eventide Asset Management, LLC

11.20%

Farallon Capital Management, L.L.C.

9.55%

Wellington Management Company, LLP

8.86%

Soleus Capital Management, L.P.

8.68%

Sands Capital Ventures LLC

8.11%

其他

53.60%

股东类型

持股股东

占比

Hedge Fund

37.25%

Investment Advisor/Hedge Fund

32.15%

Investment Advisor

23.04%

Research Firm

7.30%

Venture Capital

5.69%

Private Equity

3.62%

Individual Investor

0.63%

Sovereign Wealth Fund

0.34%

Pension Fund

0.23%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

179

48.08M

109.20%

+5.53M

2025Q2

161

44.89M

103.27%

+24.04M

2025Q1

149

45.45M

104.86%

+26.05M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Eventide Asset Management, LLC

4.93M

11.35%

+4.33K

+0.09%

Jun 30, 2025

Farallon Capital Management, L.L.C.

4.20M

9.67%

+871.70K

+26.16%

Jun 30, 2025

Wellington Management Company, LLP

3.90M

8.98%

--

Jun 30, 2025

Soleus Capital Management, L.P.

3.82M

8.79%

+424.82K

+12.51%

Jun 30, 2025

Sands Capital Ventures LLC

3.57M

8.21%

+415.70K

+13.18%

Jun 30, 2025

RTW Investments L.P.

3.30M

7.59%

-679.00

-0.02%

Jun 30, 2025

Morgan Stanley & Co. LLC

2.92M

6.72%

+1.53M

+109.41%

Jun 30, 2025

The Vanguard Group, Inc.

706.97K

1.63%

-2.29K

-0.32%

Jun 30, 2025

Omega Fund Management, LLC

1.99M

4.57%

--

Jun 30, 2025

Perceptive Advisors LLC

1.59M

3.67%

--

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

SPDR S&P Health Care Equipment ETF

0.89%

Invesco Dorsey Wright Healthcare Momentum ETF

0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.42%

Global X Internet of Things ETF

0.34%

iShares U.S. Medical Devices ETF

0.09%

Goldman Sachs Innovate Equity ETF

0.06%

iShares Russell 2000 Growth ETF

0.04%

Proshares Ultra Russell 2000

0.03%

ProShares Hedge Replication ETF

0.03%

Global X Russell 2000 ETF

0.03%

SPDR S&P Health Care Equipment ETF

占比0.89%

Invesco Dorsey Wright Healthcare Momentum ETF

占比0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.42%

Global X Internet of Things ETF

占比0.34%

iShares U.S. Medical Devices ETF

占比0.09%

Goldman Sachs Innovate Equity ETF

占比0.06%

iShares Russell 2000 Growth ETF

占比0.04%

Proshares Ultra Russell 2000

占比0.03%

ProShares Hedge Replication ETF

占比0.03%

Global X Russell 2000 ETF

占比0.03%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据